[HTML][HTML] Signaling pathways in rheumatoid arthritis: implications for targeted therapy

Q Ding, W Hu, R Wang, Q Yang, M Zhu, M Li… - Signal transduction and …, 2023 - nature.com
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease
progression leads to joint deformity and associated loss of function, which significantly …

[HTML][HTML] JAK–STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects

S Banerjee, A Biehl, M Gadina, S Hasni, DM Schwartz - Drugs, 2017 - Springer
The Janus kinase/signal transduction and activator of transcription (JAK–STAT) signaling
pathway is implicated in the pathogenesis of inflammatory and autoimmune diseases …

Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems

RL Castillo, I Sidhu, I Dolgalev, T Chu, A Prystupa… - Science …, 2023 - science.org
Whereas the cellular and molecular features of human inflammatory skin diseases are well
characterized, their tissue context and systemic impact remain poorly understood. We thus …

[HTML][HTML] Selective JAKinibs: prospects in inflammatory and autoimmune diseases

AT Virtanen, T Haikarainen, J Raivola, O Silvennoinen - BioDrugs, 2019 - Springer
Cytokines, many of which signal through the JAK–STAT (Janus kinase–Signal Transducers
and Activators of Transcription) pathway, play a central role in the pathogenesis of …

Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial

PJ Mease, DD Gladman, DH Collier… - Arthritis & …, 2019 - Wiley Online Library
Objective To examine the efficacy of methotrexate monotherapy relative to etanercept
monotherapy and the value of combining methotrexate and etanercept for the treatment of …

Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce …

P Szulc, K Naylor, NR Hoyle, R Eastell, ET Leary… - Osteoporosis …, 2017 - Springer
Abstract Summary The National Bone Health Alliance (NBHA) recommends standardized
sample handling and patient preparation for C-terminal telopeptide of type I collagen (CTX-I) …

[HTML][HTML] Role of the IL-23/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints

MA Boutet, A Nerviani, G Gallo Afflitto… - International journal of …, 2018 - mdpi.com
Psoriasis is a chronic systemic inflammatory disease causing erythematosus and scaly skin
plaques; up to 30% of patients with psoriasis develop Psoriatic Arthritis (PsA), which is …

Distinguishing rheumatoid arthritis from psoriatic arthritis

JF Merola, LR Espinoza, R Fleischmann - RMD open, 2018 - rmdopen.bmj.com
Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) have key differences in clinical
presentation, radiographic findings, comorbidities and pathogenesis to distinguish between …

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study

A Ogdie, N Kay McGill, DB Shin… - European heart …, 2018 - academic.oup.com
Aims To determine the risk of venous thromboembolism (VTE) defined as the combined
endpoint of deep venous thrombosis (DVT) and pulmonary embolism (PE) among patients …

[HTML][HTML] Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients

MT Patrick, PE Stuart, K Raja, JE Gudjonsson… - Nature …, 2018 - nature.com
Psoriatic arthritis (PsA) is a complex chronic musculoskeletal condition that occurs in~ 30%
of psoriasis patients. Currently, no systematic strategy is available that utilizes the …